Top 15 Pharmaceuticals Companies in India

Published May 8, 2023 at 10:50 am EDT Updated September 6, 2026 at 12:42 pm EDT

In this article, we will take a look at the top 15 pharmaceutical companies in India.

India is the largest producer of generic medications and vaccines worldwide. It makes up about 20% of the entire amount of generic drug supply in the world. With almost 200 nations receiving Indian pharmaceutical exports, India is a significant pharmaceutical exporter.

In addition, India has a strong network of over 10,500 production facilities, over 3,000 pharmaceutical enterprises, and a manpower pool that is highly skilled. Outside of the US, India has the most pharmaceutical manufacturing facilities that adhere to FDA rules.

More than 500 active pharmaceutical ingredients (APIs) are produced in India, supplying 60,000 generic brands. India now has the third-largest API market in the world as a result. Most supplies are made up of over-the-counter medications used to treat common ailments without endangering life. The pharmaceutical industry’s most important cities are Mumbai, Bangalore, Hyderabad, Pune, Visakhapatnam, and Ahmedabad.

One of the top-performing sectors that provide lucrative business prospects is the Indian pharmaceutical market. In recent years, it has experienced enormous expansion. As the Indian pharmaceutical business transitions from a volume maker to a valued supplier in 2022, investors are turning to this sector for safe haven investments.

In 2020, the pharmaceutical industry’s main focus was on covid medicines, but by 2022, it had turned to other serious ailments, including cancer and anaemia. In addition, research and development were highly valued in the Indian pharmaceutical business. As a result, India emerged as a global medical behemoth’ in 2022 by growing its R&D ecosystem and increasing pharmaceutical exports.

India’s pharmaceutical sector is presently worth $50 billion. A recent EY FICCI analysis projects that the Indian pharmaceutical industry will expand to $65 billion by 2024 and to $130 billion by 2030 due to a growing consensus over the need to provide patients with novel, innovative remedies. By 2023, it is anticipated that the worldwide market for pharmaceutical products will reach $1 trillion. With this outlook in mind, let’s start our list of top pharmaceuticals company in India.

Photo by National Cancer Institute on Unsplash

Our Methodology

This article will examine the biggest pharma companies in India. The companies are listed in ascending order of total employee count because larger enterprises often have a far higher staff count than smaller ones in the same industry.

Top Pharmaceuticals Companies in India

15. Intas Pharmaceuticals Limited

Number of Employees: 8,000

Intas Pharmaceuticals Limited is an Indian pharmaceutical company headquartered in Ahmedabad. It produces generic medications as well as contracts clinical research and production. It operates 18 production sites, 15 of which are in India and the remainder in the United Kingdom and Mexico. Intas has a presence in more than 85 countries and is expanding at a CAGR of over 22%.

14. Emcure Pharmaceuticals

Number of Employees: 9,000

Emcure Pharmaceuticals Limited is a multinational pharmaceutical firm based in Pune, India. Emcure’s product line includes tablets, capsules, and injectables. Emcure Pharmaceuticals’ product portfolio, which has a strong chronic and sub-chronic emphasis, includes all the key medicines and is the industry leader in fields including women’s health, blood-related illnesses, HIV, anti-infectives, cardiac care, and vitamins. Emcure Pharmaceuticals has distribution channels and a network that reaches over 70 countries. In addition, the company has 14 production plants and 5 R&D centers. Emcure Pharmaceuticals Limited generated revenue of $730 million in FY 2022.

13. Piramal Enterprises Limited (NSE:PEL.NS)

Number of Employees: 13,561

Piramal Enterprises Limited conducts operations in the financial services and pharmaceutical industries in India, North America, Europe, Japan, and other countries. Financial Services and Pharmaceuticals Manufacturing and Services are two of its operating segments. The business provides contract development and manufacturing services, such as drug discovery, production, and manufacturing of active pharmaceutical ingredients and formulations, as well as drugs for intrathecal spasticity management, inhalation and injectable anesthesia, injectable pain, antibiotics, and other medications.

12. Torrent Pharmaceuticals Limited (NSE:TORNTPHARM.NS)

Number of Employees: 13,900

Torrent Pharmaceuticals Limited is the main company of the Torrent Group and is one of the leading Pharma companies in India. The firm is among the leaders in the therapeutic area of cardiovascular, central nervous system, gastrointestinal, and women’s healthcare. Torrent Pharmaceuticals Limited in India originally introduced the idea of specialty marketing. The company is also well-represented in cancer, anti-infectives, diabetology, and pain treatment categories. Additionally, Torrent Pharma has a significant global footprint that spans 40 nations, with activities in developed and rising areas such as the US, Europe, Brazil, and the rest of the globe. The company operates through its 12 fully-owned subsidiaries, having a presence in 40 countries. In 2022, the company’s revenue was $1.1 billion.

11. Abbott India Limited (NSE:ABBOTINDIA.NS)

Number of Employees: 14,000

Abbott India Limited, located in Mumbai, is a publicly traded corporation and a subsidiary of Abbott Capital India Limited. It has one of the quickest rates of growth among Indian pharmaceutical businesses. The business offers trustworthy, high-quality drugs in various therapeutic areas, such as women’s health, gastroenterology, cardiology, metabolic disorders, central nervous system, pain management, pre-term labor, vitamins, sleeplessness, vaccinations, consumer health, etc. Thyronorm, Eptoin, Duphaston, Duphalac, Vertin, Udiliv, Heptral, Digene, Cremaffin, and Prothiaden are some of its well-known trademarks.

10. Biocon Limited (NSE:BIOCON.NS)

Number of Employees: 14,750

Biocon Limited (NSE:BIOCON.NS) makes drugs, therapeutic compounds, and herbal items. Generics, Novel Biologics, Biosimilars, and Research Services are among the company’s segments. Its primary focus areas include diabetes, cancer, immunology, ophthalmology, and bone health issues. It also offers comprehensive services for the research, development, and manufacture of both small and large molecules. The company provides customer assistance in around 120 countries, including Europe and the US. INSUGEN (rh-insulin), BASALOG (Glargine), BIOMAb EGFR (Nimotuzumab), BLISTO (Glimepiride + Metformin), CANMAb (Trastuzumab), Evertor (Everolimus), TACROGRAF (Tacrolimus), ALZUMAb (Itolizumab), and KRABEVA (Bevacizumab) are some of Biocon’s most important brands in India. The company’s consolidated revenue grew 14% to $1.1 billion in FY22.

9. Glenmark Pharmaceuticals Limited (NSE:GLENMARK.NS)

Number of Employees: 15,415

Glenmark Pharmaceuticals Limited develops, produces, and markets pharmaceutical products in India, North America, Latin America, Europe, Japan, and globally through its subsidiaries. In the therapeutic fields of dermatology, respiratory, and cancer, the firm offers both branded and generic formulations and different active pharmaceutical components. The company operates 14 production plants in Argentina, the Czech Republic, India, and the US. Numerous regulatory agencies inspect these facilities, such as the US-FDA, MHRA UK, and ANVISA Brazil. In addition, being a research-driven company, Glenmark Pharmaceuticals Limited has also made investments in special R&D facilities for international markets. Glenmark Pharmaceuticals Limited brought in $1.48 billion in sales in FY 2022.

8. Alkem Laboratories Ltd. (NSE:ALKEM.NS)

Number of Employees: 17,000

Alkem Laboratories is a pharmaceutical company with international operations. The business creates, produces, and markets pharmaceutical and nutraceutical goods. It has built a strong market position in anti-infective, gastrointestinal, pain management, vitamins, minerals, and nutritional areas, as well as acute treatment. Branded Generics, Generic Drugs, API Nutraceuticals, and Biosimilars are among the company’s product offerings. As of March 31, 2022, Alkem had 21 production facilities—19 in India and 2 in the US. Clavam, Pan 40, Taxim-O, Taxim-D, Taxim Injection, Gemcal, A to Z Tabs, Ondem, Xone, Sumo, Zocef, Pipzo, Swich, Xone XP, and Uprise D3 are some of its top brands.

7. Divi’s Laboratories (NSE:DIVISLAB:NS)

Number of Employees: 17000

Established in 1990, Divi’s Laboratories is a top producer of active pharmaceutical ingredients, exporting top-notch goods to over 95 nations. Europe accounts for most of the company’s sales, followed by North America, India, and Asia. The business views investing in mergers and acquisitions as a possible part of its operational growth plan to boost its R&D, production, and marketing capabilities. In FY22, Divi’s Laboratories generated $1.1 billion in revenue.

6. Lupin Limited (NSE:LUPIN.NS)

Number of Employees: 20,000

Lupin Limited develops, produces, distributes, and markets a wide range of biotechnology products, branded and generic formulations, and active pharmaceutical ingredients (APIs). Cardiovascular, asthma, diabetes management, pediatrics, central nervous system, gastroenterology, anti-infectives, nonsteroidal anti-inflammatory medications (NSAIDs), anti-TB, and cephalosporins are among its areas of specialization. With 18 production facilities, Lupin sells its goods in more than 100 nations. India, the US, Japan, Europe, South Africa, the Philippines, and Australia are key markets for the company. The Indian pharmaceutical firm Lupin Limited announced net revenues of $1.96 billion for the fiscal year 2022.

5. Cipla Limited (NSE:CIPLA.NS)

Number of Employees: 22,036

Cipla is an Indian pharmaceutical company with operations all over the world. The company was founded in 1935 under the name Chemical Industrial & Pharmaceutical Laboratories Ltd, and in 1984 it adopted its present name. Over 1,500 products over 65 therapeutic categories and more than 50 dosage forms make up the company’s extensive product portfolio. In FY22, it launched 93 products all over the world. Three main business divisions within the corporation make up its operations: APIs, Respiratory, and Cipla Global Access. India, followed by Africa and North America, is its biggest market. For the fiscal year 2022, Cipla Limited’s total revenue exceeded $2.9 billion.

4. Zydus Lifesciences Ltd (NSE:ZYDUSLIFE:NS)

Number of Employees: 23,000

Zydus Lifesciences Limited conducts pharmaceutical product research, development, manufacture, marketing, distribution, and sales in Africa, Europe, Latin America, the United States, and India. Zydus Lifesciences Limited has production and research facilities spread throughout five Indian states: Gujarat, Maharashtra, Goa, Himachal Pradesh, and Sikkim.

3. Aurobindo Pharma Limited (NSE:AUROPHARMA.NS)

Number of Employees: 24,000

Aurobindo Pharma Limited conducts research, develops, produces, and sells active pharmaceutical ingredients, generic medications, and associated services. The firm primarily sells oral solids, injectables, over-the-counter medications, active pharmaceutical ingredients, and final dosage forms for cancer, dermatological, respiratory, cardiovascular, gastrointestinal, and anti-allergy conditions. Around 90% of Aurobindo’s income comes from its worldwide business, which company exports to more than 155 nations. Prominent multinational corporations are some of the company’s clients.

2. Dr. Reddy’s Laboratories Limited (NYSE:RDY)

Number of Employees: 24,795

Hyderabad-based Dr. Reddy’s Laboratories Limited is a multinational pharmaceutical company in India. Kallam Anji Reddy, who had previously worked for the mentor company Indian Drugs & Pharmaceuticals Limited, founded the business. Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars, and differentiated formulations are among the range of goods and services it provides. Dr. Reddy’s produces and sells a variety of medications both domestically and abroad. Over 190 drugs, 60 active pharmaceutical ingredients (APIs) for the production of pharmaceuticals, diagnostic tools, critical care, and biotechnology are all available from the firm. Major markets for Dr. Reddy’s Laboratories Limited include the United States, India, Russia & CIS nations, and Europe. In 2022, the business made $2.83 billion in sales. The USA generated 37% of total income in FY22, followed by India (22%), Russia (9%), and others (32%).

1. Sun Pharmaceutical Industries (NSE:SUNPHARMA:NS)

Number of Employees: 38,000

Mr. Dilip Shanghvi founded the international corporation Sun Pharmaceutical Industries Limited in 1983, which offers medications for treating psychiatric illnesses. Today, the business provides formulations for various medical specialties, including cardiology, psychiatry, neurology, gastrointestinal, and diabetology. It ranks as the fourth-largest specialty generic pharmaceutical firm globally and the biggest pharmaceutical company in India. Baricitinib, brivaracetam, and dapaglifozin are among its active pharmaceutical products.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also check out our articles on 15 Biggest Indian Tech Companies and 15 Biggest Medical Device Companies in the World.